drugset / Trial / NCT00603343

Propiverine in Children Suffering From Non-Neurogenic Overactive Bladder and Urinary Incontinence

NCT00603343

Phase 3 Completed 303 enrolled APOGEPHA Arzneimittel GmbH
RandomizedParallel-groupTriple-blindTreatment

Summary

The study was conducted between 2004 and 2006 to prove efficacy and tolerability of the antimuscarinic propiverine compared to placebo in children suffering from non-neurogenic overactive bladder and urinary incontinence.

Timeline

Start
2004-06
Primary completion
2006-09
Completion
2006-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propiverine Small molecule 10 mg
Comparator Propiverine Small molecule 15 mg

Indications